Marker Therapeutics, Inc. (MRKR)
1.81
+0.05
(+2.84%)
USD |
NASDAQ |
Jan 16, 16:00
1.80
-0.01
(-0.55%)
After-Hours: 20:00
Marker Therapeutics Shareholders Equity (Annual): 18.56M for Dec. 31, 2024
Shareholders Equity (Annual) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
Shareholders' Equity Definition
Shareholder's Equity is a main portion of the balance sheet of a company that measures the net value of a company. The reason for this is because the from an accounting perspective, the balance sheet equation is Shareholder's Equity = Assets - Liabilities. A few examples of shareholder's equity of a company include retained earnings, paid in capital, and preferred stock.
Shareholders Equity (Annual) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Shareholders Equity (Annual) Benchmarks
| Viridian Therapeutics, Inc. | 671.64M |
| ADMA Biologics, Inc. | 349.02M |
| Kiniksa Pharmaceuticals International Plc | 438.44M |
| Neurocrine Biosciences, Inc. | 2.590B |
| AIM ImmunoTech, Inc. | -1.322M |